Articles with "memorial sloan" as a keyword



Photo from wikipedia

A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center.

Sign Up to like & get
recommendations!
Published in 2021 at "Neuro-oncology practice"

DOI: 10.1093/nop/npaa083

Abstract: Background Extraneural metastasis of glioma is a rare event, often occurring in patients with advanced disease. Genomic alterations associated with extraneural glioma metastasis remain incompletely understood. Methods Ten patients at Memorial Sloan Kettering Cancer Center… read more here.

Keywords: metastasis; cancer center; extraneural metastasis; memorial sloan ... See more keywords

Validation of the Memorial Sloan Kettering Gastric Cancer Post-Resection Survival Nomogram: Does It Stand the Test of Time?

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of the American College of Surgeons"

DOI: 10.1097/xcs.0000000000000251

Abstract: BACKGROUND The Memorial Sloan Kettering Cancer Center (MSK) nomogram combined both gastroesophageal junction (GEJ) and gastric cancer patients and was created in an era from patients who generally did not receive neoadjuvant chemotherapy. We sought… read more here.

Keywords: gej; memorial sloan; msk nomogram; gastric cancer ... See more keywords
Photo from academic.microsoft.com

Case of the Month from Memorial Sloan Kettering Cancer Center, New York: Managing newly‐diagnosed metastatic testicular germ cell tumor in a COVID‐19 positive patient

Sign Up to like & get
recommendations!
Published in 2020 at "Bju International"

DOI: 10.1111/bju.15157

Abstract: Abstract A 17‐year‐old young man with history of a congenital solitary left testis presented to our clinic in late April 2020 with left testicular swelling and discomfort over the preceding few weeks. The patient denied… read more here.

Keywords: kettering cancer; month memorial; sloan kettering; case month ... See more keywords
Photo by bp_miller from unsplash

The Memorial Sloan Kettering (MSK) electronic informed consent (eIC) platform for clinical trials: An operational model and suite of tools for obtaining informed consent, and managing consent documents.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.15_suppl.e18577

Abstract: e18577Background: The eIC platform was developed to reduce administrative time and effort associated with paper-based consenting, improve the IC audit trail, and augment educational alternatives fo... read more here.

Keywords: sloan kettering; consent; memorial sloan; informed consent ... See more keywords
Photo by emmashell from unsplash

Memorial Sloan Kettering-Frailty Index (MSK-FI): Validation and its relationship with postoperative outcomes of older survivors of cancer.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.34_suppl.172

Abstract: 172 Background: Older cancer patients are at higher risk for poor postoperative outcomes. We tested the validity and utility of Memorial Sloan Kettering-Frailty Index (MSK-FI) in this setting. Methods: In a single institution, prospective cohort… read more here.

Keywords: frailty; memorial sloan; frailty index; postoperative outcomes ... See more keywords
Photo from wikipedia

ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of Surgical Oncology"

DOI: 10.1245/s10434-022-11425-3

Abstract: Francys C. Verdial, MD, MPH, Anita Mamtani, MD, Kate R. Pawloski, MD, Varadan Sevilimedu, MBBS, DrPH, Timothy M. D’Alfonso, MD, Hong Zhang, MD, Mary L. Gemignani, MD, MPH, Andrea V. Barrio, MD, Monica Morrow, MD,… read more here.

Keywords: cancer; memorial sloan; center new; sloan kettering ... See more keywords
Photo from wikipedia

Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram

Sign Up to like & get
recommendations!
Published in 2023 at "Cancers"

DOI: 10.3390/cancers15082392

Abstract: Simple Summary Adjuvant treatments after breast-conserving surgery (BCS) in ductal carcinoma in situ (DCIS) have shown to reduce the risk of ipsilateral breast tumor relapse (IBTR), but its effect on overall survival remains controversial. Due… read more here.

Keywords: ductal carcinoma; carcinoma situ; external validation; memorial sloan ... See more keywords